{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:39:53Z","timestamp":1790195993614,"version":"4.1.0"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T00:00:00Z","timestamp":1595635200000},"content-version":"vor","delay-in-days":206,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BioMed Research International"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>. Rifampicin resistance (RR) is associated with mortality among tuberculosis (TB) patients coinfected with HIV. We compared the prevalence of RR among TB patients with and without HIV coinfection at the National Tuberculosis Treatment Center (NTTC) in Uganda, a TB\/HIV high burdened country. We further determined associations of RR among TB\/HIV\u2010coinfected patients. <jats:italic>Methods<\/jats:italic>. In this secondary analysis, we included adult (\u226518 years) bacteriologically confirmed TB patients that were enrolled in a cross\u2010sectional study at the NTTC in Uganda between August 2017 and March 2018. TB, RR, and bacillary load were confirmed by the Xpert\u00ae MTB\/RIF assay in the primary study. A very low bacillary load was defined as a cycle threshold value of &gt;28. We compared the prevalence of RR among TB patients with and without HIV coinfection using Pearson\u2019s chi\u2010square test. We performed logistic regression analysis to determine associations of RR among TB\/HIV\u2010coinfected patients. <jats:italic>Results<\/jats:italic>. Of the 303 patients, 182 (60.1%) were male, 111 (36.6%) had TB\/HIV coinfection, and the median (interquartile range) age was 31 (25\u201039) years. RR was found among 58 (19.1%) patients. The prevalence of RR was 32.4% (36\/111) (95% confidence interval (CI): 24\u201042) among TB\/HIV\u2010coinfected patients compared to 11.5% (22\/192) (95% CI: 7\u201317) among HIV\u2010negative TB patients (<jats:italic>p<\/jats:italic> &lt; 0.001). Among TB\/HIV\u2010coinfected patients, those with RR were more likely to be rural residents (adjusted odds ratio (aOR): 5.24, 95% CI: 1.51\u201318.21, <jats:italic>p<\/jats:italic> = 0.009) and have a very low bacillary load (aOR: 13.52, 95% CI: 3.15\u201358.08, <jats:italic>p<\/jats:italic> &lt; 0.001). <jats:italic>Conclusion<\/jats:italic>. There was a high prevalence of RR among TB\/HIV\u2010coinfected patients. RR was associated with rural residence and having a very low bacillary load among TB\/HIV\u2010coinfected patients. The findings highlight a need for universal access to drug susceptibility testing among TB\/HIV\u2010coinfected patients, especially in rural settings.<\/jats:p>","DOI":"10.1155\/2020\/2508283","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T23:30:50Z","timestamp":1595719850000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["High Prevalence of Rifampicin Resistance Associated with Rural Residence and Very Low Bacillary Load among TB\/HIV\u2010Coinfected Patients at the National Tuberculosis Treatment Center in Uganda"],"prefix":"10.1155","volume":"2020","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5852-9674","authenticated-orcid":false,"given":"Joseph Baruch","family":"Baluku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallen","family":"Mugabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Mulwana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Nassozi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Katuramu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Worodria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,7,25]]},"reference":[{"key":"e_1_2_8_1_2","series-title":"Global tuberculosis report","volume-title":"Global tuberculosis report 2019","author":"World Health Organization","year":"2019"},{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185105"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.2174\/1874613601610010034"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.10.004"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082235"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.4314\/ejhs.v23i3.10"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00131014"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4317-4"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23344-z"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1125"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2017.10.007"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1376-3"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4014-3"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1806-37132010000500016"},{"key":"e_1_2_8_15_2","article-title":"The reliability of rifampicin resistance identified on Xpert? MTB\/RIF as a proxy for multidrug-resistant tuberculosis (MDR-TB) in a reference center for MDR-TB in Rio de Janeiro, Brazil. In: C62 TUBERCULOSIS: BENCH TO BEDSIDE","volume":"201","author":"Santos A. P.","year":"2020","journal-title":"American Thoracic Society"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz491"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3741294"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.11.84"},{"key":"e_1_2_8_19_2","volume-title":"National HIV testing services policy and implementation guidelines","author":"Ministry of Health","year":"2016"},{"key":"e_1_2_8_20_2","unstructured":"BiosciencesB. BD Multitest IMK Kit 2016."},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1309\/LMFT0VCE1UGO9YGD"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.045963"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.4102\/ajlm.v7i2.781"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0213017"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2016.07.026"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4411-7"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2200-8"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-020-4997-x"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0561-z"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201312-2140OC"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30537-1"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.15.0259"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bsheal.2020.02.004"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.16.0544"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-137"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2019.07.021"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.4103\/phmj.phmj_11_18"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.05.11"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02096"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3943-1"}],"container-title":["BioMed Research International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2020\/2508283.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2020\/2508283.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2020\/2508283","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T07:35:43Z","timestamp":1735630543000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2020\/2508283"}},"subtitle":[],"editor":[{"given":"Frederick D.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1155\/2020\/2508283"],"URL":"https:\/\/doi.org\/10.1155\/2020\/2508283","archive":["Portico"],"relation":{},"ISSN":["2314-6133","2314-6141"],"issn-type":[{"value":"2314-6133","type":"print"},{"value":"2314-6141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"2020-01-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2508283"}}